Tuberculous meningitis in HIV-infected patients: Drug susceptibility and clinical outcome

AIDS

Volumn 21, Issue 3, 2007, Pages 373-374

  Cecchini, Diego ^a   Ambrosioni, Juan ^a   Brezzo, Clarisa ^a   Corti, Marcelo ^a   Rybko, Ana ^a   Perez, Marcela ^a   Poggi, Susana ^a   Ambroggi, Marta ^a  

^a 'Francisco Javier Muñiz' Hospital   (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

ETHAMBUTOL; ISONIAZID; PYRAZINAMIDE; STREPTOMYCIN;

ADULT; ARTICLE; CD4+ T LYMPHOCYTE; CLINICAL FEATURE; CONTROLLED STUDY; DRUG SENSITIVITY; FEMALE; HOSPITAL ADMISSION; HOSPITALIZATION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; MORTALITY; MULTIDRUG RESISTANCE; MYCOBACTERIUM TUBERCULOSIS; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; TREATMENT OUTCOME; TUBERCULOUS MENINGITIS; VIRUS CULTURE; VIRUS STRAIN;

ADULT; AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTITUBERCULAR AGENTS; FEMALE; HUMANS; MALE; PROGNOSIS; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; TUBERCULOSIS, MENINGEAL; TUBERCULOSIS, MULTIDRUG-RESISTANT;

EID: 33846603750     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/QAD.0b013e328012b84d     Document Type: Article

References (11)

1. Thwaites G, Bang N, Dung N, Quy H, Oanh D, Thoa N, et al. The influence of HIV infection on clinical presentation, response to treatment and outcome in adults with tuberculous meningitis. J Infect Dis 2005; 192:2134-2141.
2. Thwaites G, Nguyen D, Hoang T, Do T, Nguyen T, Nguyen Q, et al. Dexamethasone for the treatment of tuberculous meningitis in adolescents and adults. N Engl J Med 2004; 351:1741-1751.
3. Patel V, Padayatchi N, Bhigjee A, Allen J, Bhagwan B, Moodley A, Mthiyane T. Multidrug-resistant tuberculous meningitis in KwaZulu-Natal, South Africa. Clin Infect Dis 2004; 38:851-856.
4. Thwaites G, Lan N, Dung N, Quy H, Oanh D, Thoa N, et al. Effect of antituberculosis drug resistance on response to treatment and outcome in adults with tuberculous meningitis. J Infect Dis 2005; 192:79-88.
5. Ritacco V, Di Lonardo M, Reniero A, Ambroggi M, Barrera L, Dambrosi A, et al. Nosocomial spread of human immunodeficiency virus-related multidrug-resistant tuberculosis in Buenos Aires. J Infect Dis 1997; 176:748-751.
6. Waisman J, Palmero D, Guemes-Gurtubay J, Videla J, Moretti B, Cantero M, et al. Evaluation of the control measures adopted against an epidemic of AIDS-related multidrug-resistant tuberculosis in a latin-American hospital [in Spanish]. Enferm Infecc Microbiol Clin 2006; 24:71-76.
7. Cetrángolo A, Marchesini L, Isola N, Di Lonardo M, Kantor I, Ambroggi M, et al. Microbiological aspects of tuberculous meningitis [in Spanish]. Boletín de la OPS 1974; 3:215-221.
8. Canetti G, Froman S, Grosset J, Hauduroy P, Langerova M, Mahler H, et al. Mycobacteria: laboratory methods for testing drug sensitivity and resistance. Bull WHO 1963; 29:565-578.
9. Laszlo A, Rahman M, Raviglione M, Bustreo F, and the WHO/ IUATLD Network of Supranational Reference Laboratorios. Quality assurance programme for drug susceptibility testing of Mycobacterium tuberculosis in the WHO/IUATLD Supranational Laboratory Network: first round of proficiency testing. Int J Tuberc Lung Dis 1997; 1:231-238.
10. Laszlo A, Gill P, Handzel V, Hodgkin M, Helbecque D. Conventional and radiometric drug susceptibility testing of Mycobacterium tuberculosis complex. J Clin Microbiol 1983; 18:1335-1339.
11. Tuberculosis in Argentina. Evaluation of direct- smear positive pulmonary TB treatment. Cohort 2003 [in Spanish]. Argentina National TB Control Program, Technical Document PRO/TB; 2005.